ADVANTAGE OF INDUCTION THERAPY WITH ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA IN A COUNTRY WITH LIMITED TRANSFUSION RESOURCES- A MALAYSIAN EXPERIENCE
Kw. Leong et al., ADVANTAGE OF INDUCTION THERAPY WITH ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA IN A COUNTRY WITH LIMITED TRANSFUSION RESOURCES- A MALAYSIAN EXPERIENCE, European journal of haematology, 53(4), 1994, pp. 237-241
Induction of remission of acute promyelocytic leukaemia (APL) needs in
tensive blood support (16) to prevent bleeding attributed to dissemina
ted intravascular coagulation. Between 1989 and 1991, at the Universit
y Hospital in Kuala Lumpur, Malaysia, the remission rate of APL was on
ly 27% with conventional chemotherapy as a result of inadequate transf
usion resources. The use of all trans retinoic acid in induction thera
py followed by consolidation and maintenance chemotherapy has improved
the situation dramatically. Twelve patients entered the study. Ten pa
tients achieved remission (83%), indicating how ATRA had significantly
improved the results (p = 0.003). Blood component transfusions were a
lso significantly reduced (p = 0.003). Two ethnic Chinese patients dev
eloped pulmonary leucostasis. Published Chinese (2, 6) and Japanese (1
1) studies have not reported this serious adverse effect. We can now s
tate that leucostasis is not a phenomenon limited to the Western popul
ation. ATRA has proved to be extremely beneficial for patients at this
centre. Early analysis also suggests that consolidation and maintenan
ce chemotherapy has prolonged remission duration. ATRA should be made
available for the treatment of APL in all countries where there are in
adequate transfusion services.